e-ISSN 2148-0532 DOI 10.54233 Open Access · CC BY-NC-SA 4.0 Türkçe
Endoüroloji Bülteni — Endourology Bulletin Submit Manuscript
Original Article Open Access

The Rezum procedure in benign prostate hyperplasia: Initial experience at a single center in Turkey

Benign prostat büyümesinde Rezum prosedürü: Türkiye’den tek merkezli ilk deneyimlerimiz

Author information
  1. American Hospital, Urology Department
  2. Koc University, School of Medicine
Issue
Volume 15 · Issue 1
Pages
23-29
Published
January 30, 2023
DOI
https://doi.org/10.54233/endouroloji.1217490 (opens in a new tab)

Abstract

Objective: In this study, we aimed to present our initial experiences with the Rezum procedure, including voiding and sexual outcomes.

Material and Methods: A total of 24 patients who underwent the Rezum procedure between June 2021 and August 2022 were included in this retrospective study. For each procedure, 2 to 12 injections were applied to the median and lateral prostate lobes. We analyzed the baseline and follow-up data and compared the outcomes of patients with and without the median lobe of the prostate.

Results: The mean follow-up time was 7.5 months. The International Prostate Symptom Score decreased in all patients by 15 points on average (p<0.001), while the maximum urinary flow increased by 5 mL/s on average in all patients except three who had similar values (p<0.001). The post-void residual decrease was 55 mL (p<0.001). In terms of the variables examined, there was no significant difference between patients who had a median lobe and those who had not. Neither any sexual worsening nor any major complications were observed. As for minor complications, two patients had macrohematuria, four had dysuria that required non-steroidal anti-inflammatory drug therapy, and two required re-catheterization due to urinary retention.

Conclusion: The Rezum procedure is an effective and practical method, even in patients who have median lobes of the prostate, and preserves sexual functions.

More From This Issue